Results 141 to 150 of about 66,098 (241)

Gastric signet‐ring cell carcinoma in a child: A clinical case study

JPGN Reports, Volume 7, Issue 2, Page 285-288, May 2026.
Abstract Gastric signet‐ring cell carcinoma (SRCC) is a rare form of gastric cancer characterized by mucus‐rich tumor cells forming a distinctive ring‐like appearance and is exceedingly rare in children, accounting for less than 1% of all childhood malignancies.
Jiaxian Wang, Yang Yang, Jiangnan Wei, Jiayin Chen, Kezhou Yang, Chao Hui He, Ning Liu   +6 more
wiley   +1 more source

Genomic Profiling in Localized Prostate Cancer: Associations With Biochemical Recurrence and Response to Salvage Radiotherapy

Cancer Science, Volume 117, Issue 5, Page 1469-1480, May 2026.
Early screening for somatic alterations in localized prostate cancer could help predict biochemical recurrence risk and optimize salvage therapy selection. ABSTRACT The clinical significance of comprehensive genomic profiling (CGP) has been established in metastatic castration‐resistant prostate cancer (PC).
Kenji Zennami, Tetsuya Takimoto, Takuhisa Nukaya, Makoto Sumitomo, Mayu Takeda, Eiji Sugihara, Hideyuki Saya, Ryoichi Shiroki   +7 more
wiley   +1 more source

Predictive value of her-2 in breast cancer: Chemotherapy [PDF]

Archive of Oncology, 2002
Stamatović Ljiljana, Šušnjar Snežana, Nešković-Konstantinović Zora, Vasović Suzana, Tomašević Zorica I., Nikolić-Vukosavljević Dragica   +5 more
doaj   +1 more source

Distinct Clinicopathological Features of HER2‐Negative, HER2‐Low, and HER2‐Overexpressing Urothelial Carcinoma in a Large Chinese Cohort

Cancer Medicine
Purpose To investigate the expression patterns of Human Epidermal Growth Factor Receptor 2 (HER2) and their clinicopathological associations across the full spectrum (negative, low, and overexpression) in a large cohort of Chinese urothelial carcinoma ...
Shanshan Wang, Dingwei Ye, Li Yang, Fan Cheng, Tiejun Yang, Xiaoping Zhang, Zhixian Yu, Qingyun Zhang, Yong Yang   +8 more
doaj   +1 more source

c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors

Brazilian Journal of Medical and Biological Research, 2004
The objective of the present investigation was to study the expression of c-erbB-2 and MIB-1 and try to associate them with morphological features of the cell such as nuclear pleomorphism, mitotic count and histological grade in a series of 70 canine ...
Dutra A.P., Granja N.V.M., Schmitt F.C., Cassali G.D.   +3 more
doaj  

Expression of p53, c-erbB-2 and Cathepsin D in Relation to Hormone Receptors in Primary Breast Cancer

Siriraj Medical Journal, 2020
The immunohistochemical expression of p53, c-erbB-2, and cathepsin D oncogene proteins was examined in 494 primary breast carcinomas. This study aimed to investigate an association of expression of these three proteins with other variables known to be ...
Supornpim Chearskul, Kris Bhothisuwan, Smarn Onreabroi, Malika Churintrapun, Namoiy Semprasert   +4 more
doaj  

乳癌における癌遺伝子産物の免疫組織学的検討 : C-erbB-2 product を中心に [PDF]

, 1990
近年， 乳癌において癌遺伝子と予後因子との関連が注目きれているが， 未だ統ーした見解はえられていない 。その手法も核酸レベルで癌遺伝子の増幅， mutation を検出する方法と癌遺伝子産物を検出する方法に大別きれている。我々は， 新鮮凍結切片を用いてc- erbB-2 product, epidermal growthfactor receptor( EGFR), c-myc protein, estrogen receptor( ER） の免疫組織学的検討を行い既に報告しているが， 加えてc ...
田内 克典, 藤巻 雅夫, 長村 義之   +2 more
core   +1 more source

Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells [PDF]

, 2017
et al,, Ghasemi, Reza
core   +2 more sources

The Future of ErbB-1 and ErbB-2 Pathway Inhibition in Breast Cancer: Targeting Multiple Receptors

The Oncologist, 2004
The Oncologist 2004;9(suppl 3):1-3 www.TheOncologist.com Correspondence: Dennis J. Slamon, M.D., Ph.D., Department of Medicine, Hematology & Oncology, 3360 Ueberroth Building, Mail Code 707707, Los Angeles, California 90095-7077, USA. Telephone: 310-825-5193; Fax: 310-267-2310; e-mail: dslamon@mednet.ucla.edu Received March 26, 2004; accepted for ...
openaire   +2 more sources